Clinical Trial: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Brief Summary:
This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult participants with obesity or overweight and type 2 diabetes.The study will last about 77 weeks and may include up to 22 visits.
Read more